Atlas Private Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$204K Buy
718
+3
+0.4% +$878 0.09% 118
2023
Q4
$206K Buy
+715
New +$195K 0.1% 116
2023
Q2
Sell
-835
Closed -$202K 119
2023
Q1
$202K Buy
+835
New +$205K 0.12% 112
2021
Q2
Sell
-665
Closed -$165K 127
2021
Q1
$165K Hold
665
0.11% 124
2020
Q4
$153K Sell
665
-75
-10% -$17.3K 0.11% 128
2020
Q3
$188K Hold
740
0.15% 112
2020
Q2
$175K Hold
740
0.14% 113
2020
Q1
$150K Buy
740
+1
+0.1% +$218 0.14% 121
2019
Q4
$178K Buy
+739
New +$163K 0.14% 131

Other funds holding AMGN

Atlas Private Wealth Management's AMGN Position: Q1 2024 in Review

Atlas Private Wealth Management increased its Amgen (AMGN) stake by 0.42% in Q1 2024, buying an estimated $878 and bringing the position to 718 shares worth $204K. The position accounts for 0.09% of the portfolio, ranked #118.

Atlas Private Wealth Management first reported a position in AMGN in Q4 2019 and has held it in 9 quarters since. The position peaked at $206K in Q4 2023. 2,716 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

  • Atlas Private Wealth Management held 718 shares of Amgen worth $204K as of Q1 2024.
  • Atlas Private Wealth Management bought 3 Amgen shares in Q1 2024, an estimated $878.
  • Amgen made up 0.09% of Atlas Private Wealth Management's portfolio in Q1 2024, its #118 holding.
  • Atlas Private Wealth Management first reported a position in Amgen in Q4 2019 and has held it in 9 quarters since.
  • Atlas Private Wealth Management's Amgen position peaked at $206K in Q4 2023.
  • 2,716 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on Atlas Private Wealth Management's 13F filing for Q1 2024, filed 15 Apr 2024.